Wholly owned by the state-run large-scaled Red Sun Group Corporation, Jiangsu Zhongbang Pharmacy Co., Ltd. has a total investment of RMB200 million, and takes up a land of 200,000 m2. It is a hi-tech enterprise mainly developing and producing heart and brain blood vessel disease, infection, respiration system, metabolism and incretion, with the technology base of Nanjing Red Sun Engineering Technology Center and Nanjing Red Sun Biological Pharmacy Engineering Technology Center It constantly promotes the strength in the raw material synthesizing pyridine ramification, R&D of new medicine, and innovation of formulations. Meanwhile the company carries out end-reaching sales business of medicines with the support of the strong medicine operating network, sales foundation, and clinical teams of Jiangsu Haibang Pharmacy Co., Ltd. Our company has established the synthesizing workshops for bulk drug, refine-dryness-package, and solid formulations, all meeting the GMP standard.. With a perfect and rigorous quality safeguard system, the company guarantees production quality and provides a well-equipped off-sales service system.